Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease
about
Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington diseaseRecent advances in quantitative neuroproteomicsCerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human StudiesIncreased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's diseaseNeuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancerImpact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.The cerebrospinal fluid proteome in HIV infection: change associated with disease severitySimulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor.Monitoring Huntington's disease progression through preclinical and early stagesContributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsBiomarkers for Huntington's disease: an update.Challenges of Huntington's disease and quest for therapeutic biomarkers.Cerebrospinal Fluid Biomarkers for Huntington's Disease.Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function.Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.Modification of protein transfer across blood/cerebrospinal fluid barrier in response to altered plasma protein composition during development.Huntington diseaseAlzheimer disease pathology and the cerebrospinal fluid proteome
P2860
Q24292909-27F9BB08-1523-4686-9C8E-9AB5D2577AA6Q27000073-37508B0F-8E49-4242-9638-7EFA1BEF8D36Q27311994-BB05558B-B71A-4532-8601-C579C2A63334Q28072237-243D12B0-B90B-49EC-A9DB-5F47CB3CBFA2Q28477022-65EFACF0-B315-4A98-902B-86C291009FEEQ30315395-F1E3323A-35E6-4DCD-9A80-5F34358F3A8CQ33525762-FC52731A-F37E-49F7-BAF1-8ECD0DD5C7FCQ33915144-84A590CB-79D6-42CB-9DA5-D49DE31E0CCAQ33988224-1108E7E7-267A-416F-825F-A54ED84BD1F1Q34474389-9356786D-2D15-4AA0-B4CE-CD0D9B4319B1Q35663352-BF043479-9473-40FB-AF49-9D02B29348ECQ35965332-A11B46FA-ECCB-4383-947A-5B1FF482276BQ36395322-E14915D6-4AC7-4ACD-BCD7-3804BAD63986Q36459201-221F4FFF-D900-48A6-9CD3-B084B31CAFB8Q36889137-6E02B525-69D3-427B-A7D6-C45B40A7A01BQ38088407-7A0D79AD-430A-44F3-B3BD-F4D9A98957DCQ38257697-1B5A4470-0849-4687-BA2C-4E6F9CB09021Q38794551-18B73A89-6F0A-4D31-9461-59805E5B6E6EQ42070989-A7E550A9-EC6B-47FC-94E6-AA1D1BF70016Q47232763-20F136E5-2F2B-4033-980D-ECB5288E51EEQ47755754-6073A3FF-A269-445B-82A6-3D8E320CC046Q52148357-3B0E50A4-D04E-4E9B-973F-4297756FCC64Q52721984-954DE0EE-E546-4B84-8950-608CE249DDFBQ53779702-AA937D12-990C-4FDF-B60E-0E592A8DC6EBQ56083219-E3DAFC4C-CD3C-48A2-97E9-02E87741C6C2Q58857913-71C038D6-3A99-48C0-8E6D-6FDDF3B0EC48
P2860
Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Brain-specific proteins declin ...... humans with Huntington disease
@en
Brain-specific proteins declin ...... umans with Huntington disease.
@nl
type
label
Brain-specific proteins declin ...... humans with Huntington disease
@en
Brain-specific proteins declin ...... umans with Huntington disease.
@nl
prefLabel
Brain-specific proteins declin ...... humans with Huntington disease
@en
Brain-specific proteins declin ...... umans with Huntington disease.
@nl
P2093
P2860
P1476
Brain-specific proteins declin ...... humans with Huntington disease
@en
P2093
Andrew Strand
Benoit Houle
Damon H May
Gereon Poschmann
Helmut E Meyer
Jiyang Zhang
John J M Bergeron
Kai Stühler
P2860
P304
P356
10.1074/MCP.M800231-MCP200
P577
2008-11-04T00:00:00Z